Mosby's 2014 Nursing Drug Reference (61 page)

BOOK: Mosby's 2014 Nursing Drug Reference
11.76Mb size Format: txt, pdf, ePub

Canada only   Side effects:
italics
= common;
bold
= life-threatening   
Nurse Alert

benzocaine topical

See
Appendix B

 

RARELY USED
benzonatate (Rx)

(ben-zoe′na-tate)

Tessalon Perles, Zonatuss

Func. class.:
Antitussive, nonopioid

USES:

Nonproductive cough

CONTRAINDICATIONS:

Hypersensitivity

DOSAGE AND ROUTES
Calculator

• Adult and child: PO
100 mg up to tid; max 600 mg/day

Canada only   Side effects:
italics
= common;
bold
= life-threatening   
Nurse Alert

benztropine (Rx)

(benz′troe-peen)

Cogentin

Func. class.:
Cholinergic blocker, antiparkinson’s agent

Chem. class.:
Tertiary amine

ACTION:

Blockade of central acetylcholine receptors, balances cholinergic activity

USES:

Parkinson’s symptoms, EPS associated with neuroleptic products, acute dystonic reactions, hypersalivation

CONTRAINDICATIONS:

Children <3 yr, hypersensitivity, closed-angle glaucoma, myasthenia gravis, GI/GU obstruction, peptic ulcer, megacolon, prostate hypertrophy, dementia, tardive dyskinesia

Precautions:
Pregnancy (C), breastfeeding, children, geriatric patients, tachycardia, renal/hepatic disease, substance abuse history, dysrhythmias, hypo/hypertension, psychiatric patients

DOSAGE AND ROUTES
Calculator
Drug-induced EPS

• Adult: IM/IV/PO
1-4 mg daily/bid; give
PO
dose as soon as possible

• Child >3 yr: IM/IV/PO
0.02-0.05 mg/kg/dose 1-2×/day

Parkinson’s symptoms

• Adult: PO/IM
0.5-1 mg at bedtime; increase by 0.5 mg q5-6days titrated to patient response, max 6 mg/day

Acute dystonic reactions

• Adult: IM/IV
1-2 mg, may increase to 1-2 mg bid
(PO)

Available forms:
Tabs 0.5, 1, 2 mg; inj 1 mg/ml

Administer:
PO route

• 
With or after meals to prevent GI upset; may give with fluids other than water

• 
At bedtime to avoid daytime drowsiness with parkinsonism

IM route

• 
Inject deeply in muscle, use filtered needle to remove solution from ampule

IV, direct route

• 
Undiluted
IV (1 mg 5 1 ml):
give
1 mg/1 min (rarely used)

Syringe compatibilities:
Metoclopramide, perphenazine

Y-site compatibilities:
Fluconazole, tacrolimus

SIDE EFFECTS

CNS:
Anxiety, restlessness, irritability, delusions, hallucinations, headache, se
dation, depression, incoherence, dizziness, memory loss;
confusion;
delirium (geriatric patients)

CV:
Palpitations, tachycardia, hypotension, bradycardia

EENT:
Blurred vision, photophobia, dilated pupils, difficulty swallowing

GI:
Dryness of mouth, constipation
, nausea, vomiting, abdominal distress,
paralytic ileus

GU:
Urinary hesitancy/retention, dysuria

INTEG:
Rash, urticaria, dermatoses

MISC:
Increased temperature, flushing, decreased sweating,
hyperthermia, heat stroke,
numbness of fingers

PHARMACOKINETICS

PO:
Onset 1 hr, duration 6-10 hr

IM/IV:
Onset 15 min, duration 6-10 hr

INTERACTIONS

Increase:
anticholinergic effect—amantadine; antihistamines, phenothiazines, tricyclics, disopyramide, quiNIDine; reduce dose

Decrease:
absorption—antidiarrheals, antacids

Decrease:
anticholinergic effect of—cholinergic

NURSING CONSIDERATIONS
Assess:

• 
Parkinsonism:
EPS, shuffling gait, muscle rigidity, involuntary movements, loss of balance

• 
Paralytic ileus: abdominal pain, intermittent constipation/diarrhea

• 
I&O ratio; commonly causes decreased urinary output; urinary hesitancy, retention; palpate bladder if retention occurs

• 
Constipation: increase fluids, bulk, exercise if this occurs

• 
Mental status: affect, mood, CNS depression, worsening of mental symptoms during early therapy

• 
Use caution during hot weather; product may increase susceptibility to heat stroke by decreasing sweating

• 
With benztropine “buzz” or “high,” patients may imitate EPS

Perform/provide:

• 
Storage at room temp

• 
Hard candy, gum, frequent drinks to relieve dry mouth

Evaluate:

• 
Therapeutic response: absence of involuntary movements after 2 days of treatment

Teach patient/family:

• 
To report urinary hesitancy/retention, dysuria

• 
That tabs may be crushed, mixed with food, may take whole dose at bedtime if approved by prescriber

• 
Not to discontinue product abruptly; to taper off over 1 wk or withdrawal symptoms may occur (EPS, tremors, insomnia, tachycardia, restlessness); to take as directed; not to double dose

• 
To avoid driving, other hazardous activities; drowsiness/dizziness may occur

• 
To avoid OTC medications: cough, cold preparations with alcohol, antihistamines, antacids, antidiarrheals within 2 hr unless directed by prescriber

• 
To change positions slowly to prevent orthostatic hypotension

• 
To use good oral hygiene, frequent sips of water, sugarless gum for dry mouth

Canada only   Side effects:
italics
= common;
bold
= life-threatening   
Nurse Alert

bepotastine

(beh-pot′uh-steen)

Bepreve

Func. class.:
Antihistamine (ophthalmic)

Chem. class.:
Histamine 1 receptor antagonist

ACTION:

A topically active, direct H
1
- receptor antagonist and mast cell stabilizer; by reducing these inflammatory mediators, relieves the ocular pruritus associated with allergic conjunctivitis

USES:

Ocular pruritus associated with signs and symptoms of allergic conjunctivitis

CONTRAINDICATIONS:

Hypersensitivity

Precautions:
Pregnancy (C), breastfeeding, children, contact lenses

DOSAGE AND ROUTES
Calculator

• Adult/child ≥2 yrs: OPHTH
Instill 1 drop in each eye bid, max 2 drops/day in each eye

Available forms:
Ophthalmic solution 1.5%

Administer
Ophthalmic route

• 
For topical ophthalmic use only

• 
Wash hands before and after use. Tilt the head back slightly and pull the lower eyelid down with the index finger. Squeeze the prescribed number of drops into the conjunctival sac and gently close eyes for 1–2 min, do not blink

• 
Do not touch the tip of the dropper to the eye, fingertips, or other surface

• 
Wait ≥10 min after instilling the ophthalmic solution before inserting contact lenses; contact lenses should not be worn if eye is red. The preservative in this product may be absorbed by soft contact lenses

• 
Do not share ophthalmic drops with others

SIDE EFFECTS

CNS:
Headache

EENT:
Taste change, ocular irritation, pharyngitis

NURSING CONSIDERATIONS
Assess:

• 
Eyes: for itching, redness, use of soft or hard contact lenses

Evaluate:

• 
Therapeutic response: absence of redness, itching in the eyes

Teach patient/family:
Ophthalmic route

• 
Product is for topical ophthalmic use only

• 
Wash hands before and after use. Tilt the head back slightly and pull the lower eyelid down with the index finger. Squeeze the prescribed number of drops into the conjunctival sac and gently close eyes for 1–2 min, do not blink

• 
Do not touch the tip of the dropper to the eye, fingertips, or other surface

• 
Wait ≥10 min after instilling the ophthalmic solution before inserting contact lenses; contact lenses should not be worn if eye is red

• 
Do not share ophthalmic drops with others

• 
Remove
contact lenses
before use because the preservative, benzalkonium chloride, may be absorbed by soft contact lenses; product should not be used to treat contact lens–related irritation

Other books

Run the Day by Davis, Matthew C.
The Ark: A Novel by Boyd Morrison
Isolation by Dan Wells
Killing Rachel by Anne Cassidy
The Hex Breaker's Eyes by Shaun Tennant
XXX - 136 Office Slave by J. W. McKenna
Fatal Convictions by Randy Singer